The Impact of and Barriers to Cardiac Rehabilitation Following Cardiac Surgery in the Adult With Congenital Heart Disease.


Journal

Journal of cardiopulmonary rehabilitation and prevention
ISSN: 1932-751X
Titre abrégé: J Cardiopulm Rehabil Prev
Pays: United States
ID NLM: 101291247

Informations de publication

Date de publication:
01 03 2022
Historique:
entrez: 25 2 2022
pubmed: 26 2 2022
medline: 12 3 2022
Statut: ppublish

Résumé

There is a paucity of literature evaluating the impact of and barriers to participation in cardiac rehabilitation (CR) in the adult congenital heart disease population. The aims of this study were to evaluate the impact of CR on physical activity and health-related quality of life, as well as to evaluate the barriers to participation in CR in a post-operative adult congenital heart disease population. Patients ≥18 yr of age seen in the Wisconsin Adult Congenital Heart Disease Program and post-open sternotomy surgery from 2010-2015 were eligible for inclusion. Subjects were mailed a novel physical activity survey and the validated EuroQOL-5D 3L health questionnaire. A retrospective medical record review was performed to extract demographic and clinical data. One hundred thirty-five patients underwent open sternotomy surgery from 2010-2015. Of these, 22 were excluded because of intellectual disability, three opted out, and three survey packets were returned to the sender. A total of 54 of the remaining 107 patients returned completed surveys. Of these, 47 (87%) were referred to CR. Thirty-five patients completed the entire CR program (74%). Those who completed CR were more likely to develop a home/independent exercise program (P = .027). Barriers to completing CR included insurance coverage, psychiatric disease, and a perception that CR would not be of benefit. Completing CR was associated with developing a home/independent exercise program in post-sternotomy adult patients with congenital heart disease. Barriers to participating in and completing CR in this population could lead to an improved completion rate if modified.

Identifiants

pubmed: 35213870
doi: 10.1097/HCR.0000000000000622
pii: 01273116-202203000-00007
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115-119

Informations de copyright

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: None.

Références

Fu TC, Huang SC, Hsu CC, Wang CH, Wang JS. Cardiac rehabilitation in patients with heart failure. Acta Cardiol Sin. 2014;30(5):353–359.
Thomas RJ, Beatty AL, Beckie TM, et al. Home-based cardiac rehabilitation: a scientific statement from the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology. J Cardiopulm Rehabil Prev. 2019;39(4):208–225.
Pina IL, Apstein CS, Balady GJ, et al.; American Heart Association Committee on exercise, rehabilitation, and prevention. Exercise and heart failure: a statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation. 2003;107(8):1210–1225.
Kwan G, Balady GJ. Cardiac rehabilitation 2012: advancing the field through emerging science. Circulation. 2012;125(7):e369–e373.
Gierat-Haponiuk K, Haponiuk I, Jaworski R, et al. Physical activity in patients with grown-up congenital heart defects after comprehensive cardiac rehabilitation. Kardiochir Torakochirurgia Pol. 2014;11(4):452–458.
Dedieu N, Fernández L, Garrido-Lestache E, Sánchez I, Jesus Lamas M. Effects of a cardiac rehabilitation program in patients with congenital heart disease. Open J Internal Med. 2014;4:22–27. doi:10.4236/ojim.2014.41004.
Holloway TM, Chesssex C, Grace SL, Oechslin E, Spriet LL, Kovacs AH. A call for adult congenital heart disease patient participation in cardiac rehabilitation. Int J Cardiol. 2011;150(3):345–346.
Opotowsky AR, Rhodes J, Landzberg MJ, et al. A randomized trial comparing cardiac rehabilitation to standard of care for adults with congenital heart disease. World J Pediatr Congenit Heart Surg. 2018;9(2):185–193.
Sarno LA, Misra A, Siddeek H, Kheiwa A, Kobayashi D. Cardiac rehabilitation for adults and adolescents with congenital heart disease: extending beyond the typical patient population. J Cardiopulm Rehabil Prev. 2020;40(1):E1–E4.
Kovacs AH, Saidi AS, Kuhl EA, et al. Depression and anxiety in adult congenital heart disease: predictors and prevalence. Int J Cardiol. 2009;137(2):158–164.
Horner T, Liberthson R, Jellinek MS. Psychosocial profile of adults with complex congenital heart disease. Mayo Clin Proc. 2000;75(1):31–36.
Bromberg JI, Beasley PJ, D'Angelo EJ, Landzberg M, DeMaso DR. Depression and anxiety in adults with congenital heart disease: a pilot study. Heart Lung. 2003;32(2):105–110.
Kovacs AH, Kaufman TM, Broberg CS. Cardiac rehabilitation for adults with congenital heart disease: physical and psychosocial considerations. Can J Cardiol. 2018;34(10)(suppl 2):S270–S277.
Lavie CJ, Menezes AR, De Schutter A, Milani RV, Blumenthal JA. Impact of cardiac rehabilitation and exercise training on psychological risk factors and subsequent prognosis in patients with cardiovascular disease. Can J Cardiol. 2016;32(10)(suppl 2):S365–S373.
Shepherd CW, While AE. Cardiac rehabilitation and quality of life: a systematic review. Int J Nurs Stud. 2012;49(6):755–771.
Gaalema DE, Elliott RJ, Savage PD, et al. Financial incentives to increase cardiac rehabilitation participation among low-socioeconomic status patients: a randomized clinical trial. JACC Heart Fail. 2019;7(7):537–546.

Auteurs

Roni M Jacobsen (RM)

Division of Pediatric Cardiology, Department of Pediatrics, Children's Hospital of Colorado, Denver (Dr Jacobsen) and Division of Pediatric Cardiology, Department of Pediatrics (Drs D. Beacher, Earing, Ginde, Bartz, and Cohen), and Division of Cardiovascular Medicine, Department of Internal Medicine (Drs L. Beacher, Earing, Ginde, Bartz, and Cohen), Medical College of Wisconsin, Milwaukee.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH